Pernod Ricard

A year ago the Pernod Ricard share closed at €94.36; with a €100 purchase you would have received 1.060 shares, which on 08.09.2026 at a price of €60.72 would have been worth €64.35. That corresponds to a performance of -35.65 percent. The most recent market value is around €15.38 billion; stock splits and dividends are not taken into account in the calculation. » More on finanzen.net

Pernod Ricard reported net sales for fiscal year 2026 fell to €9.40bn (prior year €10.96bn, -14.2% reported; organic -3.9%). Recurring operating profit declined organically by 5.2% to €2.42bn and the operating margin fell 35 basis points to 25.8%. Sharp sales drops in the US (-14%) and China (-19%), weakness at the cognac brand Martell, and the end of merger talks with Brown-Forman weighed on the stock, which fell about 5.7% to €63.76 and moved closer to its 52-week low. » More on de.investing.com

Chanel has appointed Hélène de Tissot, until now finance chief at Pernod Ricard, as its new Chief Financial Officer. She will join in October and take on full CFO responsibility in London from January, reporting to CEO Leena Nair. De Tissot worked at Pernod Ricard for more than two decades, most recently eight years as Executive Vice President for Finance and Technology. She succeeds Philippe Blondiaux, who will retire at the end of the year. » More on de.investing.com

Indian investigators are demanding a $314 million payment from Pernod Ricard, accusing the group of concealing information about Scotch whisky imports to avoid high duties. Pernod Ricard denies the allegations, stresses compliance and is fighting the case in court; the proceedings have been ongoing since 2014. If it loses a legal battle, penalties and additional payments could exceed $600 million, roughly one-fifth of last year’s sales in India. The company also faces other proceedings in India, including an antitrust case and a sales ban in New Delhi. » More on kurier.at

Brown-Forman’s premarket stock fell nearly 6% after merger talks with Pernod Ricard were mutually ended without an agreement. J.P. Morgan downgraded Brown-Forman from “Neutral” to “Underperform” and cut its price target from $27 to $23. Brown-Forman will now focus on strategic and operational priorities, including geographic expansion; a separate roughly $15 billion offer from Sazerac is reportedly on the table but analysts view it as less likely. » More on de.investing.com